期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 54, 期 11, 页码 3982-3986出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm200272h
关键词
-
资金
- BMBF [0315418]
Inhibitors of hypoxia-inducible factor 1 (HIF-1) represent promising anticancer therapeutics. We have identified a series of potent toluidinesulfonamide HIF-1 inhibitors. However, the series was threatened by a potential liability to inhibit CYP2C9 which could cause dangerous drug drug interactions when being coadministered with other drugs. We used structure activity data from the Pub Chem database to develop a topomer CoMFA model that guided the design of novel sulfonamides with high selectivity for HIF-1 over CYP2C9 inhibition.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据